Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
HarvardTrials will no longer be available as of June 7. You can search ClinicalTrials.gov directly for Harvard-sponsored studies. If you have questions, please email us.
Check out the new look and feel of Harvard Catalyst Profiles! Learn more on our About and Help pages.

Jack Bergman, PH.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01DA035857 (BERGMAN, JACK) Mar 1, 2014 - Feb 28, 2019
    NIH/NIDA
    Pharmacologic Approaches to Prescription Opioid Addiction and Relapse Prevention
    Role: Principal Investigator
  2. R01DA031299 (BERGMAN, JACK) Jul 1, 2011 - Oct 31, 2016
    NIH/NIDA
    Alpha Adrenergic Pharmacotherapy for Polydrug (Stimulant/Opiate) Abuse
    Role: Principal Investigator
  3. R01DA031020 (BERGMAN, JACK) Sep 30, 2010 - Aug 31, 2015
    NIH/NIDA
    Candidate Medications for Cannabis Addiction: FAAH Inhibitors
    Role: Principal Investigator
  4. R01DA019205 (BERGMAN, JACK) Sep 30, 2004 - Aug 31, 2010
    NIH/NIDA
    CB-1 Antagonists for Cannabis Addiction
    Role: Principal Investigator
  5. R13DA012907 (BERGMAN, JACK) Aug 15, 1999 - Jul 31, 2000
    NIH/NIDA
    BEHAVIORAL PHARMACOLOGY SOCIETIES MEETING
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Withey SL, Paronis CA, Bergman J. Concurrent Assessment of the Antinociceptive and Behaviorally Disruptive Effects of Opioids in Squirrel Monkeys. J Pain. 2018 Mar 02. PMID: 29477761.
    View in: PubMed
  2. Fischer KD, Houston ACW, Desai RI, Doyle MR, Bergman J, Mian M, Mannix R, Sulzer DL, Choi SJ, Mosharov EV, Hodgson NW, Bechtholt A, Miczek KA, Rosenberg PA. Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine. Psychopharmacology (Berl). 2018 May; 235(5):1371-1387. PMID: 29468294.
    View in: PubMed
  3. Paronis CA, Chopda GR, Vemuri K, Zakarian AS, Makriyannis A, Bergman J. Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538. J Pharmacol Exp Ther. 2018 Mar; 364(3):485-493. PMID: 29311110.
    View in: PubMed
  4. Kangas BD, Bergman J. Touchscreen technology in the study of cognition-related behavior. Behav Pharmacol. 2017 Dec; 28(8):623-629. PMID: 29064843.
    View in: PubMed
  5. Puhl MD, Desai RI, Takagi S, Presti KT, Doyle MR, Donahue RJ, Landino SM, Bergman J, Carlezon WA, Coyle JT. N-Methyl-d-aspartate receptor co-agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse. Addict Biol. 2017 Nov 23. PMID: 29168271.
    View in: PubMed
  6. Jacobs DS, Barkin CE, Kohut MR, Bergman J, Kohut SJ. Effects of lorcaserin (Belviq®) on nicotine- and food-maintained responding in non-human primates. Drug Alcohol Depend. 2017 Dec 01; 181:94-101. PMID: 29040827.
    View in: PubMed
  7. Leonard MZ, Alapafuja SO, Ji L, Shukla VG, Liu Y, Nikas SP, Makriyannis A, Bergman J, Kangas BD. Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors. J Pharmacol Exp Ther. 2017 Dec; 363(3):314-323. PMID: 28947487.
    View in: PubMed
  8. Kohut SJ, Jacobs DS, Rothman RB, Partilla JS, Bergman J, Blough BE. Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys. Psychopharmacology (Berl). 2017 Dec; 234(23-24):3455-3465. PMID: 28889212.
    View in: PubMed
  9. Jacobs DS, Kohut SJ, Jiang S, Nikas SP, Makriyannis A, Bergman J. Acute and chronic effects of cannabidiol on ??-tetrahydrocannabinol (??-THC)-induced disruption in stop signal task performance. Exp Clin Psychopharmacol. 2016 10; 24(5):320-330. PMID: 27690502.
    View in: PubMed
  10. Kulkarni S, Nikas SP, Sharma R, Jiang S, Paronis CA, Leonard MZ, Zhang B, Honrao C, Mallipeddi S, Raghav JG, Benchama O, Järbe TU, Bergman J, Makriyannis A. Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues. J Med Chem. 2016 07 28; 59(14):6903-19. PMID: 27367336.
    View in: PubMed
  11. Kohut SJ, Bergman J. Reinforcing effectiveness of nicotine in nonhuman primates: effects of nicotine dose and history of nicotine self-administration. Psychopharmacology (Berl). 2016 07; 233(13):2451-8. PMID: 27076210.
    View in: PubMed
  12. Bergman J. Commemoration of Steve R. Goldberg; 1941-2014; age 73. Psychopharmacology (Berl). 2016 05; 233(10):1763-4. PMID: 27068480.
    View in: PubMed
  13. Desai RI, Sullivan KA, Kohut SJ, Bergman J. Influence of experimental history on nicotine self-administration in squirrel monkeys. Psychopharmacology (Berl). 2016 06; 233(12):2253-63. PMID: 27040402.
    View in: PubMed
  14. Desai RI, Doyle MR, Withey SL, Bergman J. Nicotinic effects of tobacco smoke constituents in nonhuman primates. Psychopharmacology (Berl). 2016 05; 233(10):1779-89. PMID: 26892379.
    View in: PubMed
  15. Schindler CW, Redhi GH, Vemuri K, Makriyannis A, Le Foll B, Bergman J, Goldberg SR, Justinova Z. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys. Neuropsychopharmacology. 2016 08; 41(9):2283-93. PMID: 26888056.
    View in: PubMed
  16. Kangas BD, Bergman J, Coyle JT. Touchscreen assays of learning, response inhibition, and motivation in the marmoset (Callithrix jacchus). Anim Cogn. 2016 May; 19(3):673-7. PMID: 26846231; PMCID: PMC4826304 [Available on 05/01/17].
  17. Kangas BD, Bergman J. Effects of self-administered methamphetamine on discrimination learning and reversal in nonhuman primates. Psychopharmacology (Berl). 2016 Feb; 233(3):373-80. PMID: 26490034; PMCID: PMC4841750 [Available on 02/01/17].
  18. Kangas BD, Leonard MZ, Shukla VG, Alapafuja SO, Nikas SP, Makriyannis A, Bergman J. Comparisons of ?9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates. J Pharmacol Exp Ther. 2016 Apr; 357(1):125-33. PMID: 26826191; PMCID: PMC4809315 [Available on 04/01/17].
  19. Desai RI, Bergman J. Nicotine-Targeting Nano-Vaccines for Smoking Cessation. Neuropsychopharmacology. 2016 Jan; 41(1):377-8. PMID: 26657956; PMCID: PMC4677130 [Available on 01/01/17].
  20. Kohut SJ, Bergman J, Blough BE. Effects of L-methamphetamine treatment on cocaine- and food-maintained behavior in rhesus monkeys. Psychopharmacology (Berl). 2016 Mar; 233(6):1067-75. PMID: 26713332; PMCID: PMC4761269 [Available on 03/01/17].
  21. Willner P, Bergman J, Vanderschuren L, Ellenbroek B. Pharmacological approaches to the study of social behaviour. Behav Pharmacol. 2015 Sep; 26(6):501-4. PMID: 26221829.
    View in: PubMed
  22. Willner P, Bergman J, Vanderschuren L, Ellenbroek B. Announcement of 2016 Special Issue: The behavioural pharmacology of oxytocin. Behav Pharmacol. 2015 Sep; 26(6):505. PMID: 26438917.
    View in: PubMed
  23. Desai RI, Bergman J. Effects of the Nanoparticle-Based Vaccine, SEL-068, on Nicotine Discrimination in Squirrel Monkeys. Neuropsychopharmacology. 2015 Aug; 40(9):2207-16. PMID: 25742871; PMCID: PMC4613610.
  24. Willner P, Bergman J, Vanderschuren L, Ellenbroek B. The behavioural pharmacology of the basal ganglia: in memory of Lex Cools. Behav Pharmacol. 2015 Feb; 26(1-2):1-2. PMID: 25539481.
    View in: PubMed
  25. Bergman J, Rheingold CG. Dopamine D4 Receptor Antagonists for the Treatment of Cocaine Use Disorders. CNS Neurol Disord Drug Targets. 2015; 14(6):707-15. PMID: 26022267.
    View in: PubMed
  26. Nikas SP, Sharma R, Paronis CA, Kulkarni S, Thakur GA, Hurst D, Wood JT, Gifford RS, Rajarshi G, Liu Y, Raghav JG, Guo JJ, Järbe TU, Reggio PH, Bergman J, Makriyannis A. Probing the carboxyester side chain in controlled deactivation (-)-d(8)-tetrahydrocannabinols. J Med Chem. 2015 Jan 22; 58(2):665-81. PMID: 25470070; PMCID: PMC4306527.
  27. Willner P, Bergman J, Vanderschuren L, Ellenbroek B. The behavioural pharmacology of stress. Behav Pharmacol. 2014 Sep; 25(5-6):337-9. PMID: 25083566.
    View in: PubMed
  28. Kangas BD, Bergman J. Operant nociception in nonhuman primates. Pain. 2014 Sep; 155(9):1821-8. PMID: 24968803; PMCID: PMC4157960.
  29. Head RE, Kohut S, Caine SB, Bergman J. Obituary:Nancy K.Mello,Ph.D.(March 20,1935–November 25,2013). Drug Alcohol Depend. 2014 May 01; 138:255-6. PMID: 24829974.
    View in: PubMed
  30. Desai RI, Bergman J. Methamphetamine-like discriminative-stimulus effects of nicotinic agonists. J Pharmacol Exp Ther. 2014 Mar; 348(3):478-88. PMID: 24389640; PMCID: PMC3935143.
  31. Sharma R, Nikas SP, Paronis CA, Wood JT, Halikhedkar A, Guo JJ, Thakur GA, Kulkarni S, Benchama O, Raghav JG, Gifford RS, Järbe TU, Bergman J, Makriyannis A. Controlled-deactivation cannabinergic ligands. J Med Chem. 2013 Dec 27; 56(24):10142-57. PMID: 24286207; PMCID: PMC3905450.
  32. Barrett JE, Bergman J, Katz JL, Morse WH. Peter B dews. Neuropsychopharmacology. 2013 Dec; 38(13):2733. PMID: 24217056.
    View in: PubMed
  33. Justinova Z, Mascia P, Wu HQ, Secci ME, Redhi GH, Panlilio LV, Scherma M, Barnes C, Parashos A, Zara T, Fratta W, Solinas M, Pistis M, Bergman J, Kangas BD, Ferré S, Tanda G, Schwarcz R, Goldberg SR. Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. Nat Neurosci. 2013 Nov; 16(11):1652-61. PMID: 24121737.
    View in: PubMed
  34. Bergman J, Willner P, Vanderschuren L. Current approaches to the laboratory assessment of abuse potential. Behav Pharmacol. 2013 Sep; 24(5-6):337-9. PMID: 23903241.
    View in: PubMed
  35. Kangas BD, Bergman J. Repeated acquisition and discrimination reversal in the squirrel monkey (Saimiri sciureus). Anim Cogn. 2014 Mar; 17(2):221-8. PMID: 23794073; PMCID: PMC3844073.
  36. Katz JL, Bergman J. Obituary: peter B. Dews (1922-2012). Psychopharmacology (Berl). 2013 May; 227(1):193-4. PMID: 23494237.
    View in: PubMed
  37. Kangas BD, Delatte MS, Vemuri VK, Thakur GA, Nikas SP, Subramanian KV, Shukla VG, Makriyannis A, Bergman J. Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists. J Pharmacol Exp Ther. 2013 Mar; 344(3):561-7. PMID: 23287700; PMCID: PMC3583508.
  38. Desai RI, Thakur GA, Vemuri VK, Bajaj S, Makriyannis A, Bergman J. Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs. J Pharmacol Exp Ther. 2013 Feb; 344(2):319-28. PMID: 23197773; PMCID: PMC3558821.
  39. Mello NK, Fivel PA, Kohut SJ, Bergman J. Effects of chronic buspirone treatment on cocaine self-administration. Neuropsychopharmacology. 2013 Feb; 38(3):455-67. PMID: 23072835; PMCID: PMC3547196.
  40. Paronis CA, Thakur GA, Bajaj S, Nikas SP, Vemuri VK, Makriyannis A, Bergman J. Diuretic effects of cannabinoids. J Pharmacol Exp Ther. 2013 Jan; 344(1):8-14. PMID: 23019138; PMCID: PMC3533417.
  41. Willner P, Bergman J, Vanderschuren L. Pharmacological approaches to feeding behaviour and eating disorders. Behav Pharmacol. 2012 Sep; 23(5-6):439-40. PMID: 22854303.
    View in: PubMed
  42. Bergman J, Roof RA, Furman CA, Conroy JL, Mello NK, Sibley DR, Skolnick P. Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. Int J Neuropsychopharmacol. 2013 Mar; 16(2):445-58. PMID: 22827916.
    View in: PubMed
  43. Kangas BD, Bergman J. A novel touch-sensitive apparatus for behavioral studies in unrestrained squirrel monkeys. J Neurosci Methods. 2012 Aug 15; 209(2):331-6. PMID: 22790109; PMCID: PMC3429786.
  44. Newman AH, Blaylock BL, Nader MA, Bergman J, Sibley DR, Skolnick P. Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochem Pharmacol. 2012 Oct 01; 84(7):882-90. PMID: 22781742.
    View in: PubMed
  45. Schindler CW, Justinova Z, Lafleur D, Woods D, Roschke V, Hallak H, Sklair-Tavron L, Redhi GH, Yasar S, Bergman J, Goldberg SR. Modification of pharmacokinetic and abuse-related effects of cocaine by human-derived cocaine hydrolase in monkeys. Addict Biol. 2013 Jan; 18(1):30-9. PMID: 22264200.
    View in: PubMed
  46. Bergman J, Woods J. Charles Robert (Bob) Schuster: 1930-2011. Addiction. 2011 Sep; 106(9):1707. PMID: 21815928.
    View in: PubMed
  47. Willner P, Bergman J, Vanderschuren L. Stimulus properties of drugs and the behavioural pharmacology of pain: in memory of Francis Colpaert. Behav Pharmacol. 2011 Sep; 22(5-6):379-81. PMID: 21836458.
    View in: PubMed
  48. Paronis CA, Bergman J. Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal. J Pharmacol Exp Ther. 2011 Feb; 336(2):488-95. PMID: 21051498; PMCID: PMC3033719.
  49. Desai RI, Bergman J. Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds. J Pharmacol Exp Ther. 2010 Dec; 335(3):807-16. PMID: 20847037; PMCID: PMC2993550.
  50. Willner P, Bergman J, Vanderschuren L. Non-traditional drug targets in behavioural pharmacology. Behav Pharmacol. 2010 Sep; 21(5-6):375-7. PMID: 20716969.
    View in: PubMed
  51. Desai RI, Paronis CA, Martin J, Desai R, Bergman J. Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. J Pharmacol Exp Ther. 2010 Jun; 333(3):834-43. PMID: 20190012; PMCID: PMC2879939.
  52. Willner P, Bergman J, Sanger D. Behavioural pharmacology of impulse control. Behav Pharmacol. 2009 Sep; 20(5-6):558-60. PMID: 19741302.
    View in: PubMed
  53. Bergman J. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify). Exp Clin Psychopharmacol. 2008 Dec; 16(6):475-83. PMID: 19086768.
    View in: PubMed
  54. Willner P, Bergman J, Sanger D. Behavioural genetics and its relevance to psychiatry. Behav Pharmacol. 2008 Sep; 19(5-6):371-3. PMID: 18690098.
    View in: PubMed
  55. Barrett JE, Bergman J. Peter B. Dews and pharmacological studies on behavior. J Pharmacol Exp Ther. 2008 Sep; 326(3):683-90. PMID: 18544675.
    View in: PubMed
  56. Desai RI, Neumeyer JL, Bergman J, Paronis CA. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats. Behav Pharmacol. 2007 Dec; 18(8):745-54. PMID: 17989512.
    View in: PubMed
  57. Bergman J, Delatte MS, Paronis CA, Vemuri K, Thakur GA, Makriyannis A. Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties. Physiol Behav. 2008 Mar 18; 93(4-5):666-70. PMID: 18076956; PMCID: PMC2441972.
  58. Schindler CW, Graczyk Z, Gilman JP, Negus SS, Bergman J, Mello NK, Goldberg SR. Effects of kappa opioid agonists alone and in combination with cocaine on heart rate and blood pressure in conscious squirrel monkeys. Eur J Pharmacol. 2007 Dec 08; 576(1-3):107-13. PMID: 17707792.
    View in: PubMed
  59. Desai RI, Neumeyer JL, Paronis CA, Nguyen P, Bergman J. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys. Eur J Pharmacol. 2007 Mar 08; 558(1-3):98-106. PMID: 17207791; PMCID: PMC2447824.
  60. Bergman J, Paronis CA. Measuring the reinforcing strength of abused drugs. Mol Interv. 2006 Oct; 6(5):273-83. PMID: 17035668.
    View in: PubMed
  61. Yasar S, Gaal J, Justinova Z, Bergman J. Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys. Psychopharmacology (Berl). 2005 Oct; 182(1):95-103. PMID: 15990999.
    View in: PubMed
  62. Gasior M, Bergman J, Kallman MJ, Paronis CA. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology. 2005 Apr; 30(4):758-64. PMID: 15526000.
    View in: PubMed
  63. Jutkiewicz EM, Bergman J. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions. J Pharmacol Exp Ther. 2004 Dec; 311(3):1008-15. PMID: 15292458.
    View in: PubMed
  64. Czoty PW, Ramanathan CR, Mutschler NH, Makriyannis A, Bergman J. Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors. J Pharmacol Exp Ther. 2004 Nov; 311(2):720-7. PMID: 15240827.
    View in: PubMed
  65. Czoty PW, Makriyannis A, Bergman J. Methamphetamine discrimination and in vivo microdialysis in squirrel monkeys. Psychopharmacology (Berl). 2004 Sep; 175(2):170-8. PMID: 15064912.
    View in: PubMed
  66. Gasior M, Paronis CA, Bergman J. Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys. J Pharmacol Exp Ther. 2004 Jan; 308(1):249-59. PMID: 14563783.
    View in: PubMed
  67. Sanger D, Willner P, Bergman J. Applications of behavioural pharmacology in drug discovery. Behav Pharmacol. 2003 Sep; 14(5-6):363-7. PMID: 14501250.
    View in: PubMed
  68. Neumeyer JL, Kula NS, Bergman J, Baldessarini RJ. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur J Pharmacol. 2003 Aug 08; 474(2-3):137-40. PMID: 12921854.
    View in: PubMed
  69. Yasar S, Bergman J, Munzar P, Redhi G, Tober C, Knebel N, Zschiesche M, Paronis C. Evaluation of the novel antiepileptic drug, AWD 131-138, for benzodiazepine-like discriminative stimulus and reinforcing effects in squirrel monkeys. Eur J Pharmacol. 2003 Apr 04; 465(3):257-65. PMID: 12681437.
    View in: PubMed
  70. Paronis CA, Bergman J, Neumeyer J, Baldessarini J. Effects of dopaminergic D1 agonists on eyeblinking in rats. Drug Alcohol Depend. 2003.
  71. Dews PB, O'Brien CP, Bergman J. Caffeine: behavioral effects of withdrawal and related issues. Food Chem Toxicol. 2002 Sep; 40(9):1257-61. PMID: 12204389.
    View in: PubMed
  72. Bergman J, Katz JL, Miczek KA. The experimental imperative. Psychopharmacology (Berl). 2002 Oct; 163(3-4):249-50. PMID: 12373426.
    View in: PubMed
  73. Paronis CA, Gasior M, Bergman J. Effects of cocaine under concurrent fixed ratio schedules of food and IV drug availability: a novel choice procedure in monkeys. Psychopharmacology (Berl). 2002 Oct; 163(3-4):283-91. PMID: 12373429.
    View in: PubMed
  74. Mutschler NH, Bergman J. Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys. Psychopharmacology (Berl). 2002 Apr; 160(4):362-70. PMID: 11919663.
    View in: PubMed
  75. Schindler CW, Gilman JP, Bergman J, Mello NK, Woosley RL, Goldberg SR. Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys. J Pharmacol Exp Ther. 2002 Jan; 300(1):180-7. PMID: 11752114.
    View in: PubMed
  76. Gasior M, Paronis CA, Bergman J: . Effects of nicotine on the relative reinforcing strength of food and cocaine in monkeys trained under concurrent FR30 schedules of food and cocaine availability. Drug Alcohol Depend. 2002; 66:S62.
  77. Bergman J, Yasar S, Winger G. Psychomotor stimulant effects of beta-phenylethylamine in monkeys treated with MAO-B inhibitors. Psychopharmacology (Berl). 2001 Dec; 159(1):21-30. PMID: 11797065.
    View in: PubMed
  78. Paronis CA, Cox ED, Cook JM, Bergman J. Different types of GABA(A) receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem, and midazolam in squirrel monkeys. Psychopharmacology (Berl). 2001 Aug; 156(4):461-8. PMID: 11498724.
    View in: PubMed
  79. Carey GJ, Bergman J. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists. J Pharmacol Exp Ther. 2001 Apr; 297(1):215-23. PMID: 11259547.
    View in: PubMed
  80. Gasior M, Paronis CA, Bergman J. . Effects of the dopamine D1 agonist SKF 82958 on relative reinforcing strength of cocaine in rhesus monkeys. Drug Alcohol Depend. 2001; 63:S53.
  81. Paronis CA, Gasior M, Bergman J. . Effects of heroin in a two-lever “choice” self-administration procedure in monkeys. Drug Alcohol Depend. 2001; 63:S120.
  82. Bergman J, Paronis CA, Gasior M. . Concurrent FR schedules of i.v. cocaine and food delivery: effects of dopaminergic drugs during saline availability. Drug Alcohol Depend. 2001; 63:S53.
  83. Bergman J, France CP, Holtzman SG, Katz JL, Koek W, Stephens DN. Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands. Psychopharmacology (Berl). 2000 Dec; 153(1):67-84. PMID: 11255930.
    View in: PubMed
  84. Caine SB, Negus SS, Mello NK, Bergman J. Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. Exp Clin Psychopharmacol. 2000 Aug; 8(3):404-14. PMID: 10975632.
    View in: PubMed
  85. Bergman J, Nguyen P, and Neumeyer JL. . Effects of enantiomers of SKF 83959 on eyeblinking in monkeys. FASEB J. 2000; 14(8):54.
  86. Neumeyer JL, Bergman J, Kula NS, Wu QL, Leclerc G, Nguyen P, Balessarini RJ. . Characterization of novel D1 partial agonists for the treatment of psychostimulant addiction. Society for Neuroscience. 2000.
  87. Paronis CA and Bergman J. . Naltrexone-precipitated withdrawal in buprenorphine-treated female monkeys. Drug Alcohol Depend. 2000; 60((S1)):471.
  88. Paronis CA and Bergman J. . Diazepam-induced tolerance to the response rate-decreasing effects of benzodiazepines in monkeys. FASEB J. 2000; 14(8):A1448.
  89. Caine SB, Negus SS, Mello NK, Bergman J. Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J Pharmacol Exp Ther. 1999 Oct; 291(1):353-60. PMID: 10490924.
    View in: PubMed
  90. Paronis CA, Bergman J. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys. J Pharmacol Exp Ther. 1999 Sep; 290(3):1222-9. PMID: 10454498.
    View in: PubMed
  91. Schindler CW, Gilman JP, Bergman J, Negus SS, Mello NK, Woosley RL and Goldberg SR. . Cardiovascular effects of proposed cocaine treatment agents in squirrel monkeys. In: Harris L, ed. Problems of Drug Dependence 1999: Proceedings of the 61st Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr. 1999; 180:138.
  92. Yasar S, Paronis CA, Munzar P, Tober C, Bergman J. . Evaluation of the antiepileptic drug AWD 131-138 for reinforcing and discriminative stimulus effects. Behav Pharmacol. 1999; 10:S103.
  93. Mutschler NH, Negus SS, Mello NK and Bergman J. . Modification of cocaine self-administration in rhesus monkeys by chronic treatment with the with the D1 partial agonist SKF 77434. In: Harris L, ed. Problems of Drug Dependence 1999: Proceedings of the 61st Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr. 1999; 180:111.
  94. Paronis CA and Bergman J. . Antagonism of the effects of zolpidem, zaleplon and midazolam by flumazenil and ƒÒ-CCT. FASEB J. 1999; 13:A1106.
  95. Paronis CA, Locke KW and Bergman J. . Effects of the benzodiazepine-site ligand pagoclone in squirrel monkeys. In: Harris L, ed. Problems of Drug Dependence 1999: Proceedings of the 61st Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr. 1999; 180:119.
  96. Tidey JW, Bergman J. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther. 1998 Jun; 285(3):1163-74. PMID: 9618419.
    View in: PubMed
  97. Bergman, J and Goldberg, SR. . Attenuation of cocaine self-administration in monkeys by the dopamine D1 agonist SKF 83959. In: Harris L, ed. Problems of Drug Dependence 1998: Proceedings of the 60th Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr. 1998; 179:318.
  98. Bergman J, Katz JL. Behavioral pharmacology of cocaine and determinants of abuse liability. Higgins S, Katz JL, editors. Cocaine Abuse: Behavior, Pharmacology, and Clinical Applications. 1998; 51-79.
  99. Bergman J, Mutschler N, and Jutkiewicz E. . Efficacy-dependent differences in behavioral effects of dopamine D1 agonists in monkeys. Behav Pharmacol. 1998; 9((S1)):15.
  100. Paronis CA and Bergman J. . Agonist and antagonist effects of GABAA modulators. Behav Pharmacol. 1998; 9((S1)):70.
  101. Caine, SB, Negus, SS, Mello, NK, and Bergman, J. . Effects of D1 and D2 dopamine agonists on cocaine discrimination and self-administration in rats. In: Harris L, ed. Problems of Drug Dependence 1998: Proceedings of the 60th Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr. 1998; 179:86.
  102. Bergman, J, Jutkiewicz E, and Mutschler, NH. . Behavioral effects of the D1 agonist A 77636 in squirrel monkeys. In: Harris L, ed. Problems of Drug Dependence 1998: Proceedings of the 60th Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr. 1998; 179:218.
  103. Bergman J. . Discriminative-stimulus effects of dopaminergic drugs. Behav Pharmacol. 1998; 9((S1)):105.
  104. Paronis, CA and Bergman, J. . Discriminative stimulus effects of benzodiazepine-site ligands in squirrel monkeys. In: Harris L, ed. Problems of Drug Dependence 1998: Proceedings of the 60th Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr. 1998; 179:124.
  105. Spealman RD, Bergman J, Rosenzweig-Lipson S. Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists. Psychopharmacology (Berl). 1997 Oct; 133(3):283-92. PMID: 9361335.
    View in: PubMed
  106. Carey GJ, Bergman J. Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs. Psychopharmacology (Berl). 1997 Aug; 132(3):261-9. PMID: 9292626.
    View in: PubMed
  107. Bergman J, Paronis C. Back to the Future. A Commentary on Animal Models of Anxiety: Where Next?. Behavioral Pharmacology. 1997; 8:502-504.
  108. Paronis CA and Bergman J. Apparent pA2 values of partial and selective GABAA antagonists with midazolam in monkeys. In: Harris L, ed. Problems of Drug Dependence 1997: Proceedings of the 59th Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr. 1997; 178:73.
  109. Carey G. and Bergman J. Rapid assessment of cocaine self-administration in rhesus monkeys. In: Harris L, ed. Problems of Drug Dependence 1997: Proceedings of the 59th Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr. 1997; 178:282.
  110. Bergman J, Miczek KA. The ameliorating addict: An illusion reviewed. Behavioral and Brain Sciences. 1997; 19(4):575-576.
  111. Bergman J, Koek W, Holtzman SG, Stephens DN, Katz JL, Balster RL, France CP. Agonist efficacy and medications development. Problems of Drug Dependence 1996. Proceedings of the 53rd Annual Scientific meeting. 1997; 174:44.
  112. Bergman J and Paronis CA. . Preclinical assessment of benzodiazepines and related drugs in squirrel monkeys. ACNP. 1997.
  113. Bergman J, Koek W, Holtzman SG, Stephens DN, Katz JL, Balster RL, France, CP. . Agonist efficacy and medications development. In: Harris L, ed. Problems of Drug Dependence 1996: Proceedings of the 58th Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC, NIDA Res Monogr. 1997; 174:44.
  114. Bergman J and Carey G. Behavioral effects of dopamine D1 low-efficacy agonists in monkeys. In: Harris L, ed. Problems of Drug Dependence 1997: Proceedings of the 59th Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office Washington DC. NIDA Res Monogr. 1997; 178:282.
  115. Paronis C, Bergman, J. . Apparent pA2 values of flumazenil and bretazenil with midazolam in monkeys. Pharmacologist. 1997; 39:224.
  116. Bergman J. Sense and sensibility. Commentary on Gold's 'Integration of molecular biological techniques and behavioural pharmacology' Behav Pharmacol. 1996 Nov; 7(7):621-623. PMID: 11224457.
    View in: PubMed
  117. Grech DM, Spealman RD, Bergman J. Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology (Berl). 1996 May; 125(2):97-104. PMID: 8783382.
    View in: PubMed
  118. Liguori A, Morse WH, Bergman J. Respiratory effects of opioid full and partial agonists in rhesus monkeys. J Pharmacol Exp Ther. 1996 Apr; 277(1):462-72. PMID: 8613955.
    View in: PubMed
  119. Bergman J, Spealman RD, Madras BK, Rosenzweig-Lipson S. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys. J Pharmacol Exp Ther. 1996 Mar; 276(3):942-50. PMID: 8786574.
    View in: PubMed
  120. Gatch MB, Liguori A, Negus SS, Mello NK, Bergman J, Liguori T. Naloxonazine antagonism of levorphanol-induced antinociception and respiratory depression in rhesus monkeys. Eur J Pharmacol. 1996 Feb 29; 298(1):31-6. PMID: 8867916.
    View in: PubMed
  121. Bergman J. Sense and sensibility: a commentary on Gold’s Integration of molecular biological techniques and behavioural pharmacology. Behavioral Pharmacology. 1996; 7(7):621-623.
  122. Bagley J, Carey G, and Bergman J. . The discriminative stimulus effects of clozapine in squirrel monkeys. Soc Neurosci Abstr. 1996; 22:467.
  123. Bergman, J and Carey G. . Effects of olanzapine and risperidone in clozapine-discrimination studies in monkeys. ACNP. 1996; 35:255.
  124. Bergman J, Rosenzweig-Lipson S, Spealman RD. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther. 1995 Apr; 273(1):40-8. PMID: 7714795.
    View in: PubMed
  125. Tidey J, Carey G, and Bergman J. . Some behavioral effects of clozapine and novel antipsychotics in monkeys. ACNP. 1995; 34:269.
  126. Yasar S, Bergman J. Amphetamine-like effect of l-deprenyl (selegiline) in drug discrimination studies. Clin Pharmacol Ther. 1994 Dec; 56(6 Pt 2):768-73. PMID: 7995019.
    View in: PubMed
  127. Goldberg SR, Yasar S, Bergman J, Youdim MB. Introduction: examination of clinical and preclinical pharmacologic data relating to abuse liability of l-deprenyl (selegiline). Clin Pharmacol Ther. 1994 Dec; 56(6 Pt 2):721-4. PMID: 7995013.
    View in: PubMed
  128. Rosenzweig-Lipson S, Hesterberg P, Bergman J. Observational studies of dopamine D1 and D2 agonists in squirrel monkeys. Psychopharmacology (Berl). 1994 Sep; 116(1):9-18. PMID: 7862937.
    View in: PubMed
  129. Rosenzweig-Lipson S, Bergman J. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys. Eur J Pharmacol. 1994 Aug 01; 260(2-3):237-41. PMID: 7988649.
    View in: PubMed
  130. Spealman RD, Bergman J. Opioid modulation of the discriminative stimulus effects of cocaine: comparison of µ, kappa and delta agonists in squirrel monkeys discriminating low doses of cocaine. Behav Pharmacol. 1994 Feb; 5(1):21-31. PMID: 11224248.
    View in: PubMed
  131. Grech DM, Spealman RD, Bergman J. . Discriminative stimulus effects of caffeine in methamphetamine-trained squirrel monkeys. Soc Neurosci Abstr. 1994; 20:1363.
  132. Bergman J. Preclinical assessment of cocaine antagonist drugs in squirrel monkeys. NIDA Res Monogr. 1994; 145:131-8. PMID: 8742811.
    View in: PubMed
  133. Bergman J, Carey G, Goldberg, SR. . Comparison of behavioral effects of midazolam and ipsapirone in squirrel monkeys. Behav Pharmacol. 1994; 5((S1)):114.
  134. Bergman J. Contextual determinants of drug self-administration in monkeys. In: Harris L, ed. Problems of Drug Dependence 1993: Proceedings of the 55th Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr,. 1994; 140:100.
  135. Grech DM, Spealman RD, Bergman J. . Self-administration of dopamine agonists: comparison with cocaine. In: Harris L, ed. Problems of Drug Dependence 1993: Proceedings of the 55th Annual Scientific Meeting,. The College on Problems of Drug Dependence, Inc., US Government Printing Office, Washington DC. NIDA Res Monogr. 1994; 140:222.
  136. Carey G, Bergman J. . Discriminative-stimulus effects of proposed atypical neuroleptics in clozapine-trained squirrel monkeys. Behav Pharmacol. 1994; 5((S1)):114.
  137. Rosenzweig-Lipson S, Bergman J. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys. J Pharmacol Exp Ther. 1993 Nov; 267(2):765-75. PMID: 7902432.
    View in: PubMed
  138. Rosenzweig-Lipson S, Bergman J. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys. J Pharmacol Exp Ther. 1993 Jun; 265(3):1039-46. PMID: 8099614.
    View in: PubMed
  139. Bergman J, Rosenzweig-Lipson S. . Antagonist effects of dopamine D1 partial agonists in primates. Soc Neurosci Abstr. 1993; 19((1)):311.
  140. Yasar S, Goldberg S, Bergman J. . Evaluation of psychomotor-stimulant effects of l-deprenyl in rats and monkeys. Pharmacologist. 1993; 35((3)):130.
  141. Rosenzweig-Lipson S, Bergman J. . Antagonism of the discriminative stimulus effects of the selective high-efficacy D1 agonist SKF 81297 by the atypical neuroleptic clozapine in squirrel monkeys. Soc Neurosci Abstr. 1993; 18:377.
  142. Spealman RD, Bergman J. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther. 1992 May; 261(2):607-15. PMID: 1315861.
    View in: PubMed
  143. Spealman RD, Bergman J, Madras BK, Kamien JB, Melia KF. Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine. Neurochem Int. 1992 Mar; 20 Suppl:147S-152S. PMID: 1365414.
    View in: PubMed
  144. Liguori A and Bergman J. . Opioid-antagonist effects of naltrexone and naltrindole. American Psychological Association. 1992.
  145. Rosenzweig-Lipson S, Bergman J, Spealman RD, Madras BK. Stereoselective behavioral effects of Lu 19-005 in monkeys: relation to binding at cocaine recognition sites. Psychopharmacology (Berl). 1992; 107(2-3):186-94. PMID: 1377395.
    View in: PubMed
  146. Morse WH, Bergman J. . Respiratory and behavioral effects of selected opioids in rhesus monkeys. Jap J Pharmacol. 1992; 58((S1)):23.
  147. Bergman J, Rosenzweig-Lipson S. Cocaine-antagonist effects of limited-efficacy D1 agonists. NIDA Res Monogr. 1992; 119:185-9. PMID: 1359418.
    View in: PubMed
  148. Spealman RD, Bergman J, Madras BK, Melia KF. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther. 1991 Sep; 258(3):945-53. PMID: 1679852.
    View in: PubMed
  149. Bergman J, Madras BK, Spealman RD. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys. J Pharmacol Exp Ther. 1991 Sep; 258(3):910-7. PMID: 1890625.
    View in: PubMed
  150. Spealman RD, Bergman J, Madras BK. Self-administration of the high-affinity cocaine analog 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane. Pharmacol Biochem Behav. 1991 Aug; 39(4):1011-3. PMID: 1763097.
    View in: PubMed
  151. Bergman J, Johnson SE. . Opioid antagonist effects of buprenorphine on schedule-controlled responding of rhesus monkeys. Psychopharmacology. 1990; 101 Suppl:S6.
  152. Bergman J. Psychomotor stimulant effects of the stereoisomers of chlorpheniramine. Psychopharmacology (Berl). 1990; 100(1):132-4. PMID: 1967498.
    View in: PubMed
  153. Willetts J, Bergman J, Morse WH. . Discriminative stimulus effects of opioids in U-50,488-trained squirrel monkeys. FASEB J. 1990; 4:A677.
  154. Johnson SE, Bergman J. . Differential antagonism of opioid agonists by naltrexone, quadazocine, and MR2266. FASEB J. 1990; 4:A677.
  155. Bergman J, Kamien JB, Spealman RD. Antagonism of cocaine self-administration by selective dopamine D(1) and D(2) antagonists. Behav Pharmacol. 1990; 1(4):355-363. PMID: 11175420.
    View in: PubMed
  156. Spealman RD, Madras BK, Bergman J. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J Pharmacol Exp Ther. 1989 Oct; 251(1):142-9. PMID: 2795456.
    View in: PubMed
  157. Bergman J, Madras BK, Johnson SE, Spealman RD. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther. 1989 Oct; 251(1):150-5. PMID: 2529365.
    View in: PubMed
  158. Madras BK, Fahey MA, Bergman J, Canfield DR, Spealman RD. Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther. 1989 Oct; 251(1):131-41. PMID: 2529364.
    View in: PubMed
  159. Bergman J, Warren PH. Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther. 1989 Mar; 248(3):1102-8. PMID: 2539457.
    View in: PubMed
  160. Glowa JR, Bergman J, Insel T, Newman JD. Drug effects on primate alarm vocalizations. Newman, JD, editor. The Physiological Control of Mammalian Vocalization. 1989.
  161. Bergman JW, Human DG, De Moor MM, Schulz JM. Effect of kwashiorkor on the cardiovascular system. Arch Dis Child. 1988 Nov; 63(11):1359-62. PMID: 3202643; PMCID: PMC1779151.
  162. Bergman J, Spealman RD. Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol. J Pharmacol Exp Ther. 1988 May; 245(2):471-8. PMID: 2896793.
    View in: PubMed
  163. Howell LL, Bergman J, Morse WH. Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys. J Pharmacol Exp Ther. 1988 Apr; 245(1):364-72. PMID: 2834543.
    View in: PubMed
  164. Madras BK, Bergman J, Fahey, M, Canfield D, Spealman, RD. . [3H] cocaine binding to membranes of monkey caudate putamen. Pharmacologist. 1988; 30:A197.
  165. Madras BK, Bergman J, Canfield D, Spealman RD. . [3H](-)-Cocaine binding to membranes of monkey striatum. FASEB J. 1988; 2:A1137.
  166. Bergman J, Spealman RD. . Some behavioral effects of direct and indirect dopamine agonists. FASEB J. 1988; 2:A1137.
  167. Bergman J, Spealman RD. Modulation of effects of caffeine and lorazepam by diphenhydramine in squirrel monkeys. Fed Proc. 1987; 46:1131.
  168. Bergman J, Dews PB. Dietary caffeine and its toxicity. Hathcock JN, editor. Nutritional Toxicology, Vol. II. 1987; 199-217.
  169. Bergman J, Madras BK, Canfield D, Spealman RD. . Behavioral suppressant effects of neuroleptics in monkeys: relation to dopamine D2 receptor binding. Soc Neurosci Abstr. 1987; 13:598.
  170. Bergman J, Glowa JR. Suppression of behavior by food pellet-lithium chloride pairings in squirrel monkeys. Pharmacol Biochem Behav. 1986 Nov; 25(5):973-8. PMID: 3024186.
    View in: PubMed
  171. Bergman J, Spealman RD. Some behavioral effects of histamine H1 antagonists in squirrel monkeys. J Pharmacol Exp Ther. 1986 Oct; 239(1):104-10. PMID: 2876090.
    View in: PubMed
  172. Bergman J, Spealman RD. Modulation of behavioral effects of histamine H1 antagonists and cocaine by yohimbine. Pharmacologist. 1986; 28:107.
  173. Bergman J, Dorsey L. Behavioral effects of Ro 15-1788 and pentobarbital in diazepam-tolerant squirrel monkeys. Fed Proc. 1986; 45:663.
  174. Bergman J, Hassoun J, Schuster CR. Behavioral effects of selected opiates and phencyclidine in the nondependent and cyclazocine-dependent rhesus monkey. J Pharmacol Exp Ther. 1985 Nov; 235(2):463-9. PMID: 4057082.
    View in: PubMed
  175. Bergman J, Johanson CE. The reinforcing properties of diazepam under several conditions in the rhesus monkey. Psychopharmacology (Berl). 1985; 86(1-2):108-13. PMID: 3927346.
    View in: PubMed
  176. Bergman J, Schuster CR. Behavioral effects of naloxone and nalorphine preceding and following morphine maintenance in the rhesus monkey. Psychopharmacology (Berl). 1985; 86(3):324-7. PMID: 3929303.
    View in: PubMed
  177. Bergman J, Warren PH. Differing effects of morphine on schedule-controlled behavior in the squirrel monkey depending on route of administration. Fed Proc. 1983; 42:1362.
  178. de la Garza R, Bergman J, Hartel CR. Food deprivation and cocaine self-administration. Pharmacol Biochem Behav. 1981 Jul; 15(1):141-4. PMID: 7291222.
    View in: PubMed
  179. Bergman J, Johanson CE. The effects of electric shock on responding maintained by cocaine in rhesus monkeys. Pharmacol Biochem Behav. 1981 Mar; 14(3):423-6. PMID: 7232468.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Bergman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (346)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_